Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Ageing Res Rev ; 37: 28-38, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28499883

ABSTRACT

DNA methylation at the fifth position of cytosines (5mC) represents a major epigenetic modification in mammals. The recent discovery of 5-hydroxymethylcytosine (5hmC), resulting from 5mC oxidation, is redefining our view of the epigenome, as multiple studies indicate that 5hmC is not simply an intermediate of DNA demethylation, but a genuine epigenetic mark that may play an important functional role in gene regulation. Currently, the availability of platforms that discriminates between the presence of 5mC and 5hmC at single-base resolution is starting to shed light on the functions of 5hmC. In this review, we provide an overview of the genomic distribution of 5hmC, and examine recent findings on the role of this mark and the potential consequences of its misregulation during three fundamental biological processes: cell differentiation, cancer and aging.


Subject(s)
5-Methylcytosine/analogs & derivatives , Aging/metabolism , DNA Methylation , Epigenesis, Genetic , Neoplasms/metabolism , 5-Methylcytosine/metabolism , Animals , Cell Differentiation , Cytosine , Humans , Neoplasms/genetics , Oxidation-Reduction
2.
Int J Nanomedicine ; 11: 6297-6306, 2016.
Article in English | MEDLINE | ID: mdl-27932878

ABSTRACT

Human exposure to nanomaterials and nanoparticles is increasing rapidly, but their effects on human health are still largely unknown. Epigenetic modifications are attracting ever more interest as possible underlying molecular mechanisms of gene-environment interactions, highlighting them as potential molecular targets following exposure to nanomaterials and nanoparticles. Interestingly, recent research has identified changes in DNA methylation, histone post-translational modifications, and noncoding RNAs in mammalian cells exposed to nanomaterials and nanoparticles. However, the challenge for the future will be to determine the molecular pathways driving these epigenetic alterations, the possible functional consequences, and the potential effects on health.


Subject(s)
Environmental Exposure/adverse effects , Epigenesis, Genetic/drug effects , Mammals/genetics , Nanoparticles/toxicity , Animals , DNA Methylation/drug effects , DNA Methylation/genetics , Histones/metabolism , Humans , Protein Processing, Post-Translational/drug effects
3.
J Mol Neurosci ; 58(2): 243-53, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26553261

ABSTRACT

The liver X receptor agonist, GW3965, improves cognition in Alzheimer's disease (AD) mouse models. Here, we determined if short-term GW3965 treatment induces changes in the DNA methylation state of the hippocampus, which are associated with cognitive improvement. Twenty-four-month-old triple-transgenic AD (3xTg-AD) mice were treated with GW3965 (50 mg/kg/day for 6 days). DNA methylation state was examined by modified bisulfite conversion and hybridization on Illumina Infinium Methylation BeadChip 450 k arrays. The Morris water maze was used for behavioral analysis. Our results show in addition to improvement in cognition methylation changes in 39 of 13,715 interrogated probes in treated 3xTg-AD mice compared with untreated 3xTg-AD mice. These changes in methylation probes include 29 gene loci. Importantly, changes in methylation status were mainly from synapse-related genes (SYP, SYN1, and DLG3) and neurogenesis-associated genes (HMGB3 and RBBP7). Thus, our results indicate that liver X receptors (LXR) agonist treatment induces rapid changes in DNA methylation, particularly in loci associated with genes involved in neurogenesis and synaptic function. Our results suggest a new potential mechanism to explain the beneficial effect of GW3965.


Subject(s)
Alzheimer Disease/metabolism , Benzoates/pharmacology , Benzylamines/pharmacology , DNA Methylation/drug effects , Neurogenesis , Orphan Nuclear Receptors/agonists , Synapses/drug effects , Alzheimer Disease/genetics , Animals , Female , HMGB3 Protein/genetics , HMGB3 Protein/metabolism , Liver X Receptors , Mice , Qa-SNARE Proteins/genetics , Qa-SNARE Proteins/metabolism , Retinoblastoma-Binding Protein 7/genetics , Retinoblastoma-Binding Protein 7/metabolism , Synapses/metabolism , Synaptophysin/genetics , Synaptophysin/metabolism
4.
Leukemia ; 30(1): 94-103, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26216197

ABSTRACT

The JAK-STAT pathway has a substantial role in lymphoid precursor cell proliferation, survival and differentiation. Nonetheless, the contribution of JAK2 to T-cell lymphoblastic lymphoma (T-LBL) development remains poorly understood. We have identified one activating TEL-JAK2 translocation and four missense mutations accumulated in 2 out of 16 T-LBL samples. Two of them are novel JAK2 mutations and the other two are reported for the first time in T-LBL. Notably, R683G and I682T might have arisen owing to RNA editing. Mutated samples showed different mutated transcripts suggesting sub-clonal heterogeneity. Functional approaches revealed that two JAK2 mutations (H574R and R683G) constitutively activate JAK-STAT signaling in γ2A cells and can drive the proliferation of BaF3-EpoR cytokine-dependent cell line. In addition, aberrant hypermethylation of SOCS3 might contribute to enhance the activation of JAK-STAT signaling. Of utmost interest is that primary T-LBL samples harboring JAK2 mutations exhibited increased expression of LMO2, suggesting a mechanistic link between JAK2 mutations and the expression of LMO2, which was confirmed for the four missense mutations in transfected γ2A cells. We therefore propose that active JAK2 contribute to T-LBL development by two different mechanisms, and that the use of pan-JAK inhibitors in combination with epigenetic drugs should be considered in future treatments.


Subject(s)
Janus Kinase 2/genetics , Mutation , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Adaptor Proteins, Signal Transducing/genetics , Chromosomes, Human, Pair 12 , Chromosomes, Human, Pair 9 , DNA Methylation , Humans , Janus Kinase 2/physiology , LIM Domain Proteins/genetics , Proto-Oncogene Proteins/genetics , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics , Translocation, Genetic
5.
Oncotarget ; 6(1): 368-80, 2015 Jan 01.
Article in English | MEDLINE | ID: mdl-25621889

ABSTRACT

Hypermethylation of tumor suppressor genes is one of the hallmarks in the progression of brain tumors. Our objectives were to analyze the presence of the hypermethylation of EPB41L3, RASSF2 and TSP-1 genes in 132 diffuse gliomas (astrocytic and oligodendroglial tumors) and in 10 cases of normal brain, and to establish their association with the patients' clinicopathological characteristics. Gene hypermethylation was analyzed by methylation-specific-PCR and confirmed by pyrosequencing (for EPB41L3 and TSP-1) and bisulfite-sequencing (for RASSF2). EPB41L3, RASSF2 and TSP-1 genes were hypermethylated only in tumors (29%, 10.6%, and 50%, respectively), confirming their cancer-specific role. Treatment of cells with the DNA-demethylating-agent 5-aza-2'-deoxycytidine restores their transcription, as confirmed by quantitative-reverse-transcription-PCR and immunofluorescence. Immunohistochemistry for EPB41L3, RASSF2 and TSP-1 was performed to analyze protein expression; p53, ki-67, and CD31 expression and 1p/19q co-deletion were considered to better characterize the tumors. EPB41L3 and TSP-1 hypermethylation was associated with worse (p = 0.047) and better (p = 0.037) prognosis, respectively. This observation was confirmed after adjusting the results for age and tumor grade, the role of TSP-1 being most pronounced in oligodendrogliomas (p = 0.001). We conclude that EPB41L3, RASSF2 and TSP-1 genes are involved in the pathogenesis of diffuse gliomas, and that EPB41L3 and TSP-1 hypermethylation are of prognostic significance.


Subject(s)
Brain Neoplasms/genetics , Glioma/genetics , Microfilament Proteins/genetics , Thrombospondin 1/genetics , Tumor Suppressor Proteins/genetics , Aged , Biomarkers, Tumor/analysis , Brain Neoplasms/mortality , DNA Methylation/genetics , Disease-Free Survival , Female , Fluorescent Antibody Technique , Glioma/mortality , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Prognosis , Reverse Transcriptase Polymerase Chain Reaction
6.
Genes Immun ; 16(1): 71-82, 2015.
Article in English | MEDLINE | ID: mdl-25393931

ABSTRACT

Engagement of the activating receptor NKG2D (natural killer group 2 member D) with its ligands (NKG2DL) major histocompatibility complex class I related-A and -B (MICA/B), UL-16 binding protein families (ULBPs 1-6) is important to ensure the innate immunity to tumor cells. However, these cells have developed strategies to downregulate NKG2DL expression and avoid immune recognition. We demonstrate that DNA methylation can contribute to the absence of NKG2DL expression during tumor progression. We analyzed the DNA methylation profiles for each NKG2DL by pyrosequencing in acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), hepatocellular carcinoma (HC), breast cancer and colon cancer cell lines. High levels of DNA methylation for NKG2DL were found in some tumor cell lines, mainly in AML cells. This hypermethylation was correlated with the absence of transcription for NKG2DL. Higher DNA methylation levels for MICA, ULBP1 and ULBP2 were observed in AML patients (n=60) compared with healthy donors (n=25). However, no DNA methylation for NKG2DL was found in colon cancer patients (n=44). Treatment with demethylating agents (5-azacytidine and 5-aza-2'-deoxycytidine) restored the expression of NKG2DL on the cell surface of AML cells, leading to an enhanced recognition by NKG2D-expressing cells. Our data suggest that NKG2DL may be aberrantly silenced by DNA methylation as a consequence of tumor development in AML patients.


Subject(s)
GPI-Linked Proteins/metabolism , Leukemia, Myeloid, Acute/immunology , NK Cell Lectin-Like Receptor Subfamily K/metabolism , Tumor Escape , Cell Line, Tumor , DNA Methylation , GPI-Linked Proteins/immunology , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class I/metabolism , Humans , Ligands , NK Cell Lectin-Like Receptor Subfamily K/immunology
7.
Br J Cancer ; 110(8): 2123-30, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24595004

ABSTRACT

BACKGROUND: Aberrant global DNA methylation is shown to increase cancer risk. LINE-1 has been proven a measure of global DNA methylation. The objectives of this study were to assess the association between LINE-1 methylation level and bladder cancer risk and to evaluate effect modification by environmental and genetic factors. METHODS: Bisulphite-treated leukocyte DNA from 952 cases and 892 hospital controls was used to measure LINE-1 methylation level at four CpG sites by pyrosequencing. Logistic regression model was fitted to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs). Interactions between LINE-1 methylation levels and environmental and genetic factors were assessed. RESULTS: The risk of bladder cancer followed a nonlinear association with LINE-1 methylation. Compared with subjects in the middle tertile, the adjusted OR for subjects in the lower and the higher tertiles were 1.26 (95% CI 0.99-1.60, P=0.06) and 1.33 (95% CI 1.05-1.69, P=0.02), respectively. This association significantly increased among individuals homozygous for the major allele of five single-nucleotide polymorphisms located in the phosphatidylethanolamine N-methyltransferase gene (corrected P-interaction<0.05). CONCLUSIONS: The findings from this large-scale study suggest that both low and high levels of global DNA methylation are associated with the risk of bladder cancer.


Subject(s)
DNA Methylation/genetics , Long Interspersed Nucleotide Elements/genetics , Phosphatidylethanolamine N-Methyltransferase/genetics , Urinary Bladder Neoplasms/genetics , Aged , Aged, 80 and over , CpG Islands/genetics , Female , Genetic Association Studies , Genetic Predisposition to Disease , High-Throughput Nucleotide Sequencing , Humans , Leukocytes/pathology , Male , Middle Aged , Polymorphism, Single Nucleotide , Risk Factors , Urinary Bladder Neoplasms/pathology
8.
Clin Exp Immunol ; 176(2): 255-65, 2014 May.
Article in English | MEDLINE | ID: mdl-24666184

ABSTRACT

Human adipose mesenchymal stem cells are a heterogeneous population, where cell cultures derived from single-cell-expanded clones present varying degrees of differential plasticity. This work focuses on the immunomodulatory/anti-inflammatory properties of these cells. To this end, five single-cell clones were isolated (generally called 1.X and 3.X) from two volunteers. Regarding the expression level of the lineage-characteristic surface antigens, clones 1·10 and 1·22 expressed the lowest amounts, while clones 3·10 and 3·5 expressed more CD105 than the rest and clone 1·7 expressed higher amounts of CD73 and CD44. Regarding cytokine secretion, all clones were capable of spontaneously releasing high levels of interleukin (IL)-6 and low to moderate levels of IL-8. These differences can be explained in part by the distinct methylation profile exhibited by the clones. Furthermore, and after lipopolysaccharide stimulation, clone 3.X produced the highest amounts of proinflammatory cytokines such as IL-1ß, while clones 1·10 and 1·22 highly expressed IL-4 and IL-5. In co-culture experiments, clones 1.X are, together, more potent inhibitors than clones 3.X for proliferation of total, CD3(+) T, CD4(+) T and CD8(+) T lymphocytes and natural killer (NK) cells. The results of this work indicate that the adipose stem cell population is heterogeneous in cytokine production profile, and that isolation, characterization and selection of the appropriate cell clone is a more exact method for the possible treatment of different patients or pathologies.


Subject(s)
Adipose Tissue/cytology , Cytokines/immunology , Inflammation Mediators/immunology , Mesenchymal Stem Cells/cytology , Adipose Tissue/immunology , Adipose Tissue/metabolism , CD3 Complex/immunology , CD3 Complex/metabolism , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Proliferation , Cells, Cultured , Clone Cells/cytology , Clone Cells/immunology , Clone Cells/metabolism , Cluster Analysis , Coculture Techniques , Cytokines/genetics , Cytokines/metabolism , DNA Methylation , Flow Cytometry , Humans , Inflammation Mediators/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-1beta/metabolism , Interleukin-4/genetics , Interleukin-4/immunology , Interleukin-4/metabolism , Interleukin-5/genetics , Interleukin-5/immunology , Interleukin-5/metabolism , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Mesenchymal Stem Cells/immunology , Mesenchymal Stem Cells/metabolism , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Transcriptome/genetics , Transcriptome/immunology
9.
Genes Cancer ; 4(3-4): 105-11, 2013 Mar.
Article in English | MEDLINE | ID: mdl-24020001

ABSTRACT

Sirtuins play an essential role in the cellular response to environmental stress, promoting DNA repair, telomere stability, cell cycle arrest, cellular senescence, and apoptosis. Much attention has been given to the role of sirtuins in aging and cancer development; however, less is known about their role in stem cell regulation. This review focuses in this topic and discusses the possible implications in adult stem cell aging.

10.
Diabetologia ; 55(12): 3341-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22961225

ABSTRACT

AIMS/HYPOTHESIS: Energy-dense diets that are high in fat are associated with a risk of metabolic diseases. The underlying molecular mechanisms could involve epigenetics, as recent data show altered DNA methylation of putative type 2 diabetes candidate genes in response to high-fat diets. We examined the effect of a short-term high-fat overfeeding (HFO) diet on genome-wide DNA methylation patterns in human skeletal muscle. METHODS: Skeletal muscle biopsies were obtained from 21 healthy young men after ingestion of a short-term HFO diet and a control diet, in a randomised crossover setting. DNA methylation was measured in 27,578 CpG sites/14,475 genes using Illumina's Infinium Bead Array. Candidate gene expression was determined by quantitative real-time PCR. RESULTS: HFO introduced widespread DNA methylation changes affecting 6,508 genes (45%), with a maximum methylation change of 13.0 percentage points. The HFO-induced methylation changes were only partly and non-significantly reversed after 6-8 weeks. Alterations in DNA methylation levels primarily affected genes involved in inflammation, the reproductive system and cancer. Few gene expression changes were observed and these had poor correlation to DNA methylation. CONCLUSIONS/INTERPRETATION: The genome-wide DNA methylation changes induced by the short-term HFO diet could have implications for our understanding of transient epigenetic regulation in humans and its contribution to the development of metabolic diseases. The slow reversibility suggests a methylation build-up with HFO, which over time may influence gene expression levels.


Subject(s)
DNA Methylation , Diet, High-Fat , Muscle, Skeletal/metabolism , Cation Transport Proteins/genetics , CpG Islands/genetics , Cross-Over Studies , Cyclin-Dependent Kinase Inhibitor p15/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , DNA Methylation/genetics , Epigenesis, Genetic , Gene Expression , Heat-Shock Proteins/genetics , Homeodomain Proteins/genetics , Humans , Insulin Resistance/genetics , Male , Muscle, Skeletal/physiology , Overnutrition , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Proto-Oncogene Proteins c-akt/genetics , Real-Time Polymerase Chain Reaction , Trans-Activators/genetics , Transcription Factors/genetics , Young Adult , Zinc Transporter 8
11.
Oncogene ; 31(15): 1988-94, 2012 Apr 12.
Article in English | MEDLINE | ID: mdl-21892211

ABSTRACT

The Kruppel-like factor (KLF) proteins are multitasked transcriptional regulators with an expanding tumor suppressor function. KLF2 is one of the prominent members of the family because of its diminished expression in malignancies and its growth-inhibitory, pro-apoptotic and anti-angiogenic roles. In this study, we show that epigenetic silencing of KLF2 occurs in cancer cells through direct transcriptional repression mediated by the Polycomb group protein Enhancer of Zeste Homolog 2 (EZH2). Binding of EZH2 to the 5'-end of KLF2 is also associated with a gain of trimethylated lysine 27 histone H3 and a depletion of phosphorylated serine 2 of RNA polymerase. Upon depletion of EZH2 by RNA interference, short hairpin RNA or use of the small molecule 3-Deazaneplanocin A, the expression of KLF2 was restored. The transfection of KLF2 in cells with EZH2-associated silencing showed a significant anti-tumoral effect, both in culture and in xenografted nude mice. In this last setting, KLF2 transfection was also associated with decreased dissemination and lower mortality rate. In EZH2-depleted cells, which characteristically have lower tumorigenicity, the induction of KLF2 depletion 'rescued' partially the oncogenic phenotype, suggesting that KLF2 repression has an important role in EZH2 oncogenesis. Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.


Subject(s)
DNA-Binding Proteins/metabolism , Kruppel-Like Transcription Factors/metabolism , Neoplasms/metabolism , Transcription Factors/metabolism , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Breast Neoplasms/metabolism , Enhancer of Zeste Homolog 2 Protein , Female , Humans , Kruppel-Like Transcription Factors/genetics , Male , Mice , Mice, Nude , Neoplasm Transplantation , Neoplasms/genetics , Polycomb Repressive Complex 2 , Prostatic Neoplasms/metabolism , RNA Interference , Transfection
12.
J Mol Med (Berl) ; 90(5): 587-95, 2012 May.
Article in English | MEDLINE | ID: mdl-22120039

ABSTRACT

The bromodomain protein BRD4 is involved in cell proliferation and cell cycle progression, primarily through its role in acetylated chromatin-dependent regulation of transcription at targeted loci. Here, we show that BRD4 is frequently downregulated by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumors. Ectopic re-expression of BRD4 in these colon cancer cell lines markedly reduced in vivo tumor growth, suggesting a role of BRD4 in human colon cancer.


Subject(s)
Colonic Neoplasms/genetics , Epigenesis, Genetic , Gene Expression Regulation, Neoplastic , Nuclear Proteins/genetics , Transcription Factors/genetics , Acetylation , Animals , Cell Cycle Proteins , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , DNA Methylation/genetics , Gene Silencing , Histones/metabolism , Humans , Mice , Nuclear Proteins/metabolism , Promoter Regions, Genetic/genetics , Repressor Proteins/genetics , Repressor Proteins/metabolism , Transcription Factors/metabolism
13.
Oncogene ; 29(10): 1405-20, 2010 Mar 11.
Article in English | MEDLINE | ID: mdl-20101211

ABSTRACT

Viruses are associated with 15-20% of human cancers worldwide. In the last century, many studies were directed towards elucidating the molecular mechanisms and genetic alterations by which viruses cause cancer. The importance of epigenetics in the regulation of gene expression has prompted the investigation of virus and host interactions not only at the genetic level but also at the epigenetic level. In this study, we summarize the published epigenetic information relating to the genomes of viruses directly or indirectly associated with the establishment of tumorigenic processes. We also review aspects such as viral replication and latency associated with epigenetic changes and summarize what is known about epigenetic alterations in host genomes and the implications of these for the tumoral process. The advances made in characterizing epigenetic features in cancer-causing viruses have improved our understanding of their functional mechanisms. Knowledge of the epigenetic changes that occur in the genome of these viruses should provide us with markers for following cancer progression, as well as new tools for cancer therapy.


Subject(s)
Epigenesis, Genetic , Neoplasms/genetics , Viral Proteins/physiology , Virus Diseases/genetics , Viruses/metabolism , CpG Islands/genetics , DNA Methylation , Histones/metabolism , Humans , Methylation , Neoplasms/metabolism , Neoplasms/virology , Viral Proteins/genetics , Viral Proteins/metabolism , Virus Diseases/metabolism , Virus Diseases/virology , Viruses/genetics
14.
Surg Endosc ; 17(1): 153-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12399873

ABSTRACT

BACKGROUND: We show the experience of 6 years in laparoscopic surgical therapy of esophageal achalasia, performing of the Heller-Dor or Heller-Toupet operation, with particular regard to the technical aspect. METHODS: One hundred and ten laparoscopic interventions were done between November 1995 and December 2001. We studied operative time in hiatus approach, esophagocardiomyotomy, transoperative endoscopy, and anti-reflux procedure. We also analyzed the relation between complications and clinical evolution of disease with clinical stage. RESULTS: The mean surgical time of the intervention is 138 min, and it is significantly increased by transoperative endoscopic control; conversion to open surgery was not necessary. Clinical results are classified as excellent in 103 patients. Morbidity was 6%. CONCLUSION: This surgical procedure is a first line in the treatment of esophageal achalasia. It is necessary to have special care in early diagnostic cases to avoid electrosurgical injury.


Subject(s)
Esophageal Achalasia/surgery , Laparoscopy/statistics & numerical data , Adolescent , Adult , Aged , Cuba/epidemiology , Esophagoscopy/statistics & numerical data , Female , Follow-Up Studies , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Recurrence , Treatment Outcome
15.
An Med Interna ; 19(10): 539-43, 2002 Oct.
Article in Spanish | MEDLINE | ID: mdl-12481500

ABSTRACT

Haematological abnormalities are frequently encountered in patients with systemic lupus erythematosus (SLE). Anaemia is the most common hematological abnormality in SLE, it is multifactorial. The most common form of anaemia is that of chronic disease, and it is relate with inflammatory cytokines. Other tips of anaemia are: iron deficiency anaemia, autoimmune haemolytic anaemia, pure red cell aplasia. Leucopenia is related to neutropenia and/or lymphopenia. Thrombocytopenia is common, autoimmune and associated with a decreased survival. The presence of antiphospholipid antibodies increase risk of thrombosis in patients with SLE.


Subject(s)
Hematologic Diseases/etiology , Lupus Erythematosus, Systemic/complications , Humans
16.
An. med. interna (Madr., 1983) ; 19(10): 539-543, oct. 2002.
Article in Es | IBECS | ID: ibc-17179

ABSTRACT

Las alteraciones hematológicas son frecuentes en el lupus eritematoso sistémico (LES). La anemia es la más común y es de naturaleza multifactorial. El tipo más frecuente es la anemia de las enfermedades crónicas, que está en relación con las citoquinas de la inflamación; otros tipos son: la anemia ferropénica, anemia hemolítica autoinmune, aplasia pura de glóbulos rojos. La leucopenia está en relación a la neutropenia y/o linfopenia. La trombocitopenia es común, su causa es autoinmune y se asocia a disminución de la sobrevida. La presencia de anticuerpos antifosfolípidos (AAF) incrementa el riesgo de trombosis en el LES (AU)


Subject(s)
Humans , Lupus Erythematosus, Systemic , Hematologic Diseases
18.
Dis Aquat Organ ; 33(2): 87-92, 1998 Jun 19.
Article in English | MEDLINE | ID: mdl-9684314

ABSTRACT

Siderophore production, presence of iron-regulated outer membrane proteins and siderophore specificity was determined among 17 isolates of Aeromonas salmonicida subsp. salmonicida obtained from Spain and Scotland. All grew in the presence of ethylenediamine di(o-hydroxyphenylacetic acid) (EDDA) and siderophore production was detected using chrome azurol S (CAS) agar, confirming the presence of a high-affinity siderophore iron-uptake mechanism. The Arnow test confirmed that all isolates produced a catechol siderophore. Cross-feeding assays with indicator bacteria showed the absence of anguibactin, enterobactin, 2,3-dihydroxybenzoic acid (DHBA) and the hydroxamate siderophore, aerobactin, in the iron-restricted supernants of a representative isolate which cross fed 15/17 A. salmonicida isolates tested. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) showed the presence of the same 2 major iron-regulated outer membrane proteins (IROMPs) in all isolates when grown in iron-restricted conditions and siderophore strain specificity as assessed by cross-feeding experiments was not apparent. Thus, with respect to IROMP and siderophore production A. salmonicida appears to be a homogeneous species.


Subject(s)
Aeromonas/metabolism , Salmonidae/microbiology , Siderophores/biosynthesis , Aeromonas/growth & development , Animals , Bacterial Outer Membrane Proteins/biosynthesis , Chelating Agents/metabolism , Culture Media , Edetic Acid/analogs & derivatives , Edetic Acid/metabolism , Fish Diseases/microbiology , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/veterinary , Iron/metabolism , Species Specificity
19.
Caribe Contemp ; (20): 91-100, 1990.
Article in Spanish | MEDLINE | ID: mdl-12343283

ABSTRACT

PIP: Recent trends in illegal migration from the Dominican Republic to Puerto Rico are analyzed. The authors suggest that this migration is predominantly driven by economic factors, and that chain migration is a frequent occurrence.^ieng


Subject(s)
Economics , Emigration and Immigration , Employment , Transients and Migrants , Americas , Caribbean Region , Demography , Developing Countries , Dominican Republic , Latin America , North America , Population , Population Dynamics , Puerto Rico , Social Class , Socioeconomic Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...